Multidisciplinary Treatment for Glioblastoma


The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did this E-Learning module provide a good update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastoma? (1: no, not at all; 5: yes, absolutely)

2. Did this E-Learning module describe best practices and current treatment recommendations? (1: no, not at all; 5: yes, absolutely)

3. Did this E-Learning module provide an update on recent clinical trials and ongoing research seeking to improve treatment outcomes? (1: no, not at all; 5: yes, absolutely)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: